US2004204568A1PendingUtilityA1

Molecules designated LDCAM

57
Assignee: IMMUNEX CORPPriority: Aug 7, 1998Filed: Jul 17, 2003Published: Oct 14, 2004
Est. expiryAug 7, 2018(expired)· nominal 20-yr term from priority
Inventors:Peter Robert BaumWilliam C. Fanslow, Iii
A61P 37/04C07K 2319/00A61K 38/00C07K 14/70503A61P 31/00A61P 29/00A61P 35/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is directed to LDCAM as a purified and isolated protein, the DNA encoding the LDCAM, host cells transfected with cDNAs encoding LDCAM, processes for preparing LDCAM polypeptides and compositions and methods for treating utilizing LDCAM polypeptides.

Claims

exact text as granted — not AI-modified
1 . An isolated DNA sequence encoding a polypeptide that is at least 80% identical with the sequence of amino acid residues selected from the group consisting of 1 to 442 of SEQ ID NO:2 and 1 to 423 of SEQ ID NO:4, the polypeptide being capable of binding to itself.  
     
     
         2 - 17 . (Canceled).  
     
     
         18 . An isolated antibody immunoreactive with LDCAM.  
     
     
         19 . The antibody of  claim 18 , wherein LDCAM comprises SEQ ID NO:2.  
     
     
         20 . The antibody of  claim 18 , wherein LDCAM comprises SEQ ID NO:4.

Join the waitlist — get patent alerts

Track US2004204568A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.